tiprankstipranks
BofA trims Denali Therapeutics price target to $30, says weakness an opportunity
PremiumThe FlyBofA trims Denali Therapeutics price target to $30, says weakness an opportunity
2M ago
Denali Therapeutics price target lowered to $32 from $35 at BTIG
Premium
The Fly
Denali Therapeutics price target lowered to $32 from $35 at BTIG
2M ago
Denali Therapeutics price target lowered to $87 from $90 at H.C. Wainwright
Premium
The Fly
Denali Therapeutics price target lowered to $87 from $90 at H.C. Wainwright
2M ago
Denali Therapeutics announces HEALEY ALS trial regimen misses endpoints
PremiumThe FlyDenali Therapeutics announces HEALEY ALS trial regimen misses endpoints
2M ago
Denali falls 9% to $18 afteramyotrophic lateral sclerosis study miss
Premium
The Fly
Denali falls 9% to $18 afteramyotrophic lateral sclerosis study miss
2M ago
Denali Therapeutics initiated with an Outperform at Baird
Premium
The Fly
Denali Therapeutics initiated with an Outperform at Baird
2M ago
Denali Therapeutics management to meet with B. Riley
PremiumThe FlyDenali Therapeutics management to meet with B. Riley
3M ago
Denali Therapeutics Advances Brain Disease Therapies
Premium
Company Announcements
Denali Therapeutics Advances Brain Disease Therapies
3M ago
Denali Therapeutics sees Fy24 opex increase of 5%-10% year-over-year
Premium
The Fly
Denali Therapeutics sees Fy24 opex increase of 5%-10% year-over-year
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100